-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX regains Nasdaq compliance after reverse split lifts shares above US$1 bid threshold

PUBT·04/21/2026 11:03:02
Listen to the news
XORTX regains Nasdaq compliance after reverse split lifts shares above US$1 bid threshold
  • XORTX Therapeutics regained compliance with Nasdaq minimum bid price requirement.
  • Compliance followed a 1-for-5 reverse share split implemented April 6, 2026.
  • Common shares met threshold by trading at or above US$1 for 10 consecutive sessions, achieved April 17, 2026.
  • Nasdaq issued compliance letter April 20, 2026, clearing the bid-price deficiency.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XORTX Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604210700PRIMZONEFULLFEED9693737) on April 21, 2026, and is solely responsible for the information contained therein.